Medicine catalog

Search official names, active ingredients, and BDPM codes. Cards show a readable name and form; the exact French source details are available below.

Total in catalog: 20,854 · 7 shown

Commercialized according to BDPM

VITRAKVI 100 mg, hard capsule

Active ingredients: Larotrectinib, Larotrectinib sulfate

Original BDPM details in French

Official name: VITRAKVI 100 mg, gélule
Active ingredients: LAROTRECTINIB, SULFATE DE LAROTRECTINIB
Package description: 1 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 56 gélule(s)

CIS 64373909CIP7 3018800CIP13 3400930188002

View details

Estimated price€14,561.80No current ANSM shortage notice is included

Commercialized according to BDPM

VITRAKVI 20 mg/ml, oral solution

Active ingredients: Larotrectinib, Larotrectinib sulfate

Original BDPM details in French

Official name: VITRAKVI 20 mg/mL, solution buvable
Active ingredients: LAROTRECTINIB, SULFATE DE LAROTRECTINIB
Package description: 2 flacon(s) en verre avec fermeture de sécurité enfant de 50 ml

CIS 65942815CIP7 3023034CIP13 3400930230343

View details

Estimated price€5,374.10No current ANSM shortage notice is included

Commercialized according to BDPM

VITRAKVI 25 mg, hard capsule

Active ingredients: Larotrectinib, Larotrectinib sulfate

Original BDPM details in French

Official name: VITRAKVI 25 mg, gélule
Active ingredients: LAROTRECTINIB, SULFATE DE LAROTRECTINIB
Package description: 1 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 56 gélule(s)

CIS 67022406CIP7 3018799CIP13 3400930187999

View details

Estimated price€3,822.92No current ANSM shortage notice is included

Commercialized according to BDPM

ALECENSA 150 mg, hard capsule

Active ingredients: Alectinib, Alectinib hydrochloride

Original BDPM details in French

Official name: ALECENSA 150 mg, gélule
Active ingredients: ALECTINIB, CHLORHYDRATE D'ALECTINIB
Package description: 4 plaquettes thermoformées polyamide aluminium PVC de 56 gélules 224 (4x56)

CIS 60639892CIP7 3008304CIP13 3400930083048

View details

Estimated price€7,675.24No current ANSM shortage notice is included

Structural formula: Lapatinib ditosylate hydrate

Commercialized according to BDPM

TYVERB 250 mg, film-coated tablet

Active ingredients: Lapatinib ditosylate hydrate, Lapatinib

Original BDPM details in French

Official name: TYVERB 250 mg, comprimé pelliculé
Active ingredients: DITOSILATE DE LAPATINIB MONOHYDRATÉ, LAPATINIB
Package description: flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 70 comprimé(s)

CIS 65609052CIP7 4170176CIP13 3400941701764

View details

Estimated price€1,862.84No current ANSM shortage notice is included

Commercialized according to BDPM

TYVERB 250 mg, film-coated tablet

Active ingredients: Lapatinib ditosylate hydrate, Lapatinib

Original BDPM details in French

Official name: TYVERB 250 mg, comprimé pelliculé
Active ingredients: DITOSILATE DE LAPATINIB MONOHYDRATÉ, LAPATINIB
Package description: flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 140 comprimé(s)

CIS 65609052CIP7 4170182CIP13 3400941701825

View details

Estimated price€3,653.90No current ANSM shortage notice is included

Commercialized according to BDPM

TYVERB 250 mg, film-coated tablet

Active ingredients: Lapatinib ditosylate hydrate, Lapatinib

Original BDPM details in French

Official name: TYVERB 250 mg, comprimé pelliculé
Active ingredients: DITOSILATE DE LAPATINIB MONOHYDRATÉ, LAPATINIB
Package description: flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 84 comprimé(s)

CIS 65609052CIP7 4170199CIP13 3400941701993

View details

Estimated price€2,220.78No current ANSM shortage notice is included

The displayed price is an estimate. It is not an offer to sell or confirmation of stock. Current catalog version published 4 Nov 2026.